Back

State of the Art: cardiovascular genetics and gene therapy in cardiovascular diseases

28 August 2017 (14:00 - 14:18)
Organised by:
Congress Presentation Part of: Genetics and gene therapy in cardiovascular diseases Genetics and gene therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Dierk Thomas

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
Correcting the PRKAG2 mutation in WPW patient's induced pluripotent stem cells using CRISPR/Cas9 eliminates arrhythmic firing patterns in the derived cardiomyocytes
Mr R. Ben Jehuda (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Restoration of normal sinus node physiology in a model of sick sinus syndrome; Tbx18 overexpression improves heart rate, rate stability and adrenergic response.
Doctor N. Black (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
A heart-enriched antisense long non-coding RNA regulates the balance between cardiac and skeletal muscle triadin
Mrs L. Zhang (Luxembourg, LU)
Abstract Slides Video
Presentation thumbnail
Perspectives and challenges of genetic correction and gene editing
Professor E. McNally (Chicago, US)
Slides Video

Access the full session

Session thumbnail
Genetics and gene therapy in cardiovascular diseases

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023
thumbnail
Congress Presentation
Gene therapy targeting intimal hyperplasia
31 August 2025
thumbnail
Congress Presentation
Towards advanced cardiac miRNA therapies through DNA-based nanostructures
29 April 2022
thumbnail
Webinar
Induced-pluripotent stem cells (iPSC) technology for cardiac repair
17 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources